Study for children and adults with chordoma
Part of Cancer clinical trials.
This trial studies people with chordoma (a rare bone/soft-tissue tumor) and collects information and samples to learn more about the disease. It may help by improving understanding of chordoma and supporting future research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your legal representative) can understand the study and sign a written consent form
- You must have chordoma confirmed by scan results or biopsy (tissue test)
- You must be at least 2 years old
- You must be enrolled in NCI study 19-C-0016 for rare solid tumors (natural history and sample collection)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two standard treatment approaches—surgery versus definitive radiation—for people with a primary sacral chordoma (a bone tumor at the lower spine/pelvis area). It aims to find which approach works best for controlling the tumor while considering treatment side effects.
This trial is testing a better way to plan proton radiation using MRI images, aiming to deliver treatment more accurately for chordoma or chondrosarcoma in the spine/sacrum area. You may benefit if the trial’s planning method helps target the tumor while sparing nearby healthy tissue.
This trial tests whether analyzing blood and tumor samples before and after radiation and surgery can help find personalized markers for chordoma. It is for patients with chordoma of the skull base, spine, or sacrum who will receive radiation before surgery.
This study collects tumor (or related) samples to analyze their genes and build a shared research “biobank.” It may help researchers understand cancers better for future diagnosis and treatments.
This study follows children and adults with medullary thyroid cancer (MTC) and/or MEN2 to better understand how the condition progresses over time. It may help doctors plan care in the future by collecting long-term health and lab information, not by giving a new treatment.
This study follows people (and sometimes family members) connected to rare solid tumors and collects health information and samples (biospecimens). It helps researchers understand how these cancers develop and builds resources for future research, which may benefit you by contributing to better tailored care for rare cancers.
Hear when a new Chordoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.